The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Changes in net revenues as compared to the first quarter of the prior year were primarily driven by: BAQSIMI® sales decreased primarily due to a lower average selling price, as a result of a change in ...

Image source: The Motley Fool. Management revealed plans to file and launch a proprietary soft mist inhaler, "Tresmi," which reduces inhaler-related cough by up to 90% based on conducted human studies ...

Management revealed plans to file and launch a proprietary soft mist inhaler, "Tresmi," which reduces inhaler-related cough by up to 90% based on conducted human studies. New cartridge and dosing ...

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and ...

The Food and Drug Administration is pulling Primatene Mist from the market Jan. 1. The ban is the result of the Montreal Protocol treaty, which prohibits the sale of certain products containing ...